Surgery Partners Inc (1SP) Quote

Watch *LIVE* Hearings, Pam Bondi ~ Rubio >

https://youtu.be/DQWmVqIZjJY

premkt Boooooom !

FNMA $7.60 55,000

FMCC $6.96 40,000

Watch *LIVE* Hearings, Pam Bondi ~ Rubio >

https://youtu.be/DQWmVqIZjJY

Did a mixed shelf offering a few hits .60 + 29%

$ILLR: #Triller could easily become your biggest winner ever or your biggest miss; you decide.
Your future is waiting on your decision.

REMEMBER: #TRILLER IS BACKED BY BILLIONAIRES. (let that sink in--we will win)
https://youtu.be/IER6hvocp0w

Watch *LIVE* Hearings, Pam Bondi ~ Rubio >

https://youtu.be/DQWmVqIZjJY

$ILLR: #Triller could easily become your biggest winner ever or your biggest miss; you decide.
Your future is waiting on your decision.

REMEMBER: #TRILLER IS BACKED BY BILLIONAIRES. (let that sink in--we will win)
https://youtu.be/IER6hvocp0w

I believe so! Looking forward to seeing Reggie post on X at some point ~Rig

All these posts about this, that and the other thing...when nothing really matters but what revs look like a few months from now...which all the technical posts will have no influence on...maybe you guys are practicing to join a debating team?

LOL Good morning

Now we understand LOL

The "STORY" is XERI has been a SCAM from the START. They will NEVER own any XTIA stock and Nexboard is as fictitious as the XTIA stock they were to get from a SCAM XTI JV/MERGER along with the SCAM Movychem JV. There are 2 XERI BS lawsuits that have already been Dismissed. Now we are waiting for 2

No pinks or otcbbs on this board…

Well would you look at that, Elite passed with flying colors on the Shortage page again.
I have never seen them in shortage for generic Adderall

https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amp

Looks good! I think our patience is going to pay nicely with MONI ... and good mornin' ...

yup no name change from finra as yet,i just checked.

It’s coming brothers 🚀🚀🚀An SRC is a group of clinicians and other experts that oversee patient safety during a clinical trial. The SRC determines whether and how a study should proceed, including dose escalation and de-escalation decisions in accordance with the study design

$ADTX Looking for bounce today. Extremely Oversold at this level. Swinging for 100-200% here! Market Cap only $1.9M!

https://investorshub.advfn.com/uimage/uploads/2025/1/15/wywwpADTX.png

$2.61 as soon as news hits, they short over 75% of them for the time being ~Rig

Today would be a good day to release some positive information. Let's build the next level base around .25-.30

Thank you in advance 

The peer reviewed paper has been published in the JPAD Journal

https://www.sciencedirect.com/science/article/pii/S2274580724006083

Good luck and GOD bless,

PHIO: A very SMART-CITY idea, Boss!!!

~WINT .24 news out, trying to come off bottom for the pop trade ~Rig

Q3 2024 (last year same period). I agree they probably have more than 1 batch a month but it’s my low estimate for Q3 2025